Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases. It is engaged in the production of drugs that elicit anti-tumor and anti-HIV effects of bone marrow or stem cell transplant procedures while eliminating the side effects and the need for a tissue matched donor. The company develops AlloStim, a bioengineered living cell allograft, and Chaperone-Rich Cell Lysate (CRCL), a patient-specific heat shock protein vaccine.